KLK3 and prostate carcinoma: In prostate cancer diagnostics, Du et al. [176] designed prostate-specific antigen (PSA)-targeted manganese-doped mesoporous silica nanoparticles (PSA-Mn-MSN-Cy7) for dual-modal fluorescence and MRI imaging.